• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖细胞核抗原(PCNA)在鼻息肉中的表达:一项系统评价和荟萃分析

Expression of Proliferating Cell Nuclear Antigen (PCNA) in Nasal Polyp: A Systematic Review and Meta-analysis.

作者信息

Soltanipur Masood, Rohani Bastami Mohammadhosein, Shahshenas Sina, Ghorbanniadelavar Zahra, Barouh Alireza, Shadmand Alireza, Karimi Nemch Mohammadreza, Yarmohammadi Hossein, Siadat Seyed Davar, Jalali Nadoushan Mohammadreza

机构信息

Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.

General Practitioner (GP), Avicenna Hospital, Tehran, Iran.

出版信息

Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):608-619. doi: 10.1007/s12070-024-05172-y. Epub 2024 Nov 1.

DOI:10.1007/s12070-024-05172-y
PMID:40066409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11890497/
Abstract

UNLABELLED

Nasal polyp (NP) is a pathological benign mass that affects the nasal cavity and paranasal sinuses. This lesion is occasionally associated with chronic rhinosinusitis (CRS), which is named chronic rhinosinusitis with nasal polyps (CRSwNP). Proliferating cell nuclear antigen (PCNA) indicates abnormal cell proliferation which may help assess the nasopharyngeal lesions and upper airway cancers. This study aimed to examine the PCNA expression in NP tissue. This study was conducted under the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A thorough search using relevant keywords was performed on the electronic database to identify studies examining the PCNA expression in NP. Meta-analysis on pooled single group proportion and means of PCNA expression was conducted by the metamean and metaprop functions in R software (version 4.4.0). Quality assessment was done according to the Joanna Briggs Institute (JBI) checklist. Ten articles were included in this study. The PCNA expression in NP was higher than in normal nasal mucosa (NNM), while its expression in NP was lower than in inverted papilloma (IP). The mean percentage of PCNA expression in NP was 15.73% (95%-CI[2.87-28.58]) with considerable heterogeneity (  = 97%[96-98%],-value < 0.01). Based on a cutoff staining (> 5%), 64% of NP samples were PCNA-positive (95%-CI[42-81%]) with high heterogeneity (  = 76%[47-89%], -value < 0.01). NP tissue has a relatively high expression of the PCNA oncoprotein based on the immunohistochemistry (IHC) staining. Although more than half of NP samples were positive for PCNA, still the mean expression of this marker in NP was lower than in IP tissue.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12070-024-05172-y.

摘要

未标注

鼻息肉(NP)是一种影响鼻腔和鼻窦的病理性良性肿物。这种病变偶尔与慢性鼻窦炎(CRS)相关,后者被称为伴鼻息肉的慢性鼻窦炎(CRSwNP)。增殖细胞核抗原(PCNA)表明细胞异常增殖,这可能有助于评估鼻咽部病变和上呼吸道癌症。本研究旨在检测NP组织中PCNA的表达情况。本研究按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行。在电子数据库中使用相关关键词进行全面检索,以识别检测NP中PCNA表达的研究。通过R软件(版本4.4.0)中的metamean和metaprop函数对PCNA表达的合并单组比例和均值进行Meta分析。根据乔安娜·布里格斯研究所(JBI)清单进行质量评估。本研究纳入了10篇文章。NP中PCNA的表达高于正常鼻黏膜(NNM),而其在NP中的表达低于内翻性乳头状瘤(IP)。NP中PCNA表达的平均百分比为15.73%(95%置信区间[2.87 - 28.58]),具有相当大的异质性(I² = 97%[96 - 98%],P值<0.01)。基于截断染色(>5%),64%的NP样本PCNA呈阳性(95%置信区间[42 - 81%]),具有高度异质性(I² = 76%[47 - 89%],P值<0.01)。基于免疫组织化学(IHC)染色,NP组织中PCNA癌蛋白表达相对较高。尽管超过一半的NP样本PCNA呈阳性,但该标志物在NP中的平均表达仍低于IP组织。

补充信息

在线版本包含可在10.1007/s12070 - 024 - 05172 - y获取的补充材料。

相似文献

1
Expression of Proliferating Cell Nuclear Antigen (PCNA) in Nasal Polyp: A Systematic Review and Meta-analysis.增殖细胞核抗原(PCNA)在鼻息肉中的表达:一项系统评价和荟萃分析
Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):608-619. doi: 10.1007/s12070-024-05172-y. Epub 2024 Nov 1.
2
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.鼻内用类固醇与安慰剂或不干预治疗慢性鼻-鼻窦炎的比较
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011996. doi: 10.1002/14651858.CD011996.pub2.
3
Systemic and topical antibiotics for chronic rhinosinusitis.用于慢性鼻-鼻窦炎的全身及局部用抗生素
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011994. doi: 10.1002/14651858.CD011994.pub2.
4
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease.用于非甾体抗炎药(NSAID)诱发的呼吸道疾病的口服和鼻内阿司匹林脱敏疗法。
Cochrane Database Syst Rev. 2025 Jan 7;1(1):CD013476. doi: 10.1002/14651858.CD013476.pub2.
5
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Different types of intranasal steroids for chronic rhinosinusitis.用于慢性鼻-鼻窦炎的不同类型鼻内类固醇
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011993. doi: 10.1002/14651858.CD011993.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Short-course oral steroids alone for chronic rhinosinusitis.短期口服类固醇单独用于慢性鼻窦炎。
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011991. doi: 10.1002/14651858.CD011991.pub2.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Evaluation of the Relationship between CD44 Expression and Gleason Grade among Prostate Adenocarcinoma and Benign Prostatic Hyperplasia: A Cross-Sectional Study.前列腺腺癌与良性前列腺增生中CD44表达与Gleason分级之间关系的评估:一项横断面研究。
Med Princ Pract. 2025;34(3):271-280. doi: 10.1159/000544021. Epub 2025 Feb 11.

本文引用的文献

1
Comparison of B-cell lymphoma 2 (BCL-2) expression in disordered proliferative endometrium and simple endometrial hyperplasia.比较紊乱增生的子宫内膜和单纯性子宫内膜增生中 B 细胞淋巴瘤 2(BCL-2)的表达。
Rev Esp Patol. 2024 Oct-Dec;57(4):265-272. doi: 10.1016/j.patol.2024.05.005. Epub 2024 Jul 2.
2
Comparison of Proliferating Cell Nuclear Antigen (PCNA) Expression among Nasal Polyp and Chronic Rhinosinusitis.比较鼻息肉和慢性鼻-鼻窦炎中增殖细胞核抗原(PCNA)的表达。
Acta Otorrinolaringol Esp (Engl Ed). 2024 Sep-Oct;75(5):310-315. doi: 10.1016/j.otoeng.2024.02.003. Epub 2024 May 7.
3
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features.不同年龄组鼻息肉的形态学:组织病理学特征
J Pers Med. 2024 Apr 14;14(4):414. doi: 10.3390/jpm14040414.
4
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis.慢性鼻-鼻窦炎伴鼻息肉:发病机制中的嗜酸性粒细胞与 B 淋巴细胞。
Curr Opin Allergy Clin Immunol. 2024 Feb 1;24(1):15-24. doi: 10.1097/ACI.0000000000000959. Epub 2023 Nov 27.
5
Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma.细胞角蛋白-7和细胞角蛋白-19表达与前列腺腺癌Gleason评分的关系评估
Iran J Pathol. 2023 Summer;18(3):363-369. doi: 10.30699/IJP.2023.2002657.3116. Epub 2023 Aug 18.
6
Characterization of Cytokines and Proliferation Marker Ki-67 in Chronic Rhinosinusitis with Recurring Nasal Polyps.慢性鼻-鼻窦炎伴鼻息肉中细胞因子和增殖标志物 Ki-67 的特征。
Adv Respir Med. 2022 Oct 14;90(5):451-466. doi: 10.3390/arm90050053.
7
Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.与慢性鼻-鼻窦炎鼻息肉严重程度相关的鼻分泌物中类二十烷酸的水平。
Prostaglandins Leukot Essent Fatty Acids. 2022 Sep;184:102474. doi: 10.1016/j.plefa.2022.102474. Epub 2022 Jul 23.
8
The effects of proliferating cell nuclear antigen and in patients with oral squamous cell carcinoma: a systematic review and meta-analysis.增殖细胞核抗原在口腔鳞状细胞癌患者中的作用:一项系统评价和荟萃分析。
Ann Transl Med. 2021 Dec;9(23):1739. doi: 10.21037/atm-21-6133.
9
Recorded prevalence of nasal polyps increases with age.鼻息肉的记录患病率随年龄增长而增加。
Postepy Dermatol Alergol. 2021 Aug;38(4):682-688. doi: 10.5114/ada.2020.99365. Epub 2020 Oct 13.
10
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
Int J Surg. 2021 Apr;88:105906. doi: 10.1016/j.ijsu.2021.105906. Epub 2021 Mar 29.